Approved
Form OMB
No. 0920-1026 Exp.
Date: 07/31/2017
OMB Approved
0920-XXXX
Expiration Date xx/xx/xxxx
CDC Assigned ID: ....................... State/territory reporting this case: ..................................... Case No: .........................
Patient name (last, first):
Date of symptom onset of this attack (mm/dd/yyyy): ____/ ____/ _____ |
Age: _______ yrs. mos. wks. days (circle units) Date of Birth: ____/ ____/ ________ |
|
Physician name (last, first):
Telephone Number: ( ) _________ – ___________ |
Ethnicity: Hispanic or Latino Not Hispanic or Latino Unknown |
Race (select one or more): American Indian/Alaska Native Native Hawaiian/Other Pacific Islander Black or African American Asian White Unknown |
Symptom History |
Yes |
No |
When
did the |
When did the patient first seek medical attention:
Date:
____/ ____/ ________ Patient admitted to hospital: Yes No Unknown
Yes No Unknown
Date: ____/ ____/ ________
Initial diagnosis: ____________________ (ICD-9 code)
Final diagnosis: ____________________ (ICD-9 code)
Is the patient insured? Yes No Unknown
|
|
|
|
|
|
Fever |
|
|
____/ ____/ ________ |
|
Nausea |
|
|
|
|
Vomiting |
|
|
|
|
Diarrhea |
|
|
|
|
Upper respiratory symptoms (cough, congestion) |
|
|
|
|
Rash |
|
|
|
|
Altered mental status |
|
|
|
|
Jaundice |
|
|
|
|
|
|
|
|
Laboratory Tests |
||||||||||
|
Yes |
No |
Unknown |
Date and time test done mm/dd/yyyy hh:mm |
Results |
Date and time results available mm/dd/yyyy hh:mm |
||||
CBC |
|
|
|
___/___/______ |
__ __ : __ __ |
am pm |
N/A |
___/___/______ |
__ __ : __ __ |
am pm |
Chemistry panel |
|
|
|
___/___/______ |
__ __ : __ __ |
am pm |
N/A |
___/___/______ |
__ __ : __ __ |
am pm |
|
|
|
|
|
|
|
|
|
|
|
Tested for malaria? |
|
|
|
___/___/______ |
__ __ : __ __ |
am pm |
|
|
|
|
Microscopy
|
|
|
|
___/___/______ |
__ __ : __ __ |
am pm |
positive negative |
___/___/______ |
__ __ : __ __ |
am pm |
Microscopy
|
|
|
|
___/___/______ |
__ __ : __ __ |
am pm |
positive negative |
___/___/______ |
__ __ : __ __ |
am pm |
RDT (Binax Now) |
|
|
|
___/___/______ |
__ __ : __ __ |
am pm |
positive negative |
___/___/______ |
__ __ : __ __ |
am pm |
PCR |
|
|
|
___/___/______ |
__ __ : __ __ |
am pm |
positive negative |
___/___/______ |
__ __ : __ __ |
am pm |
Antibody testing |
|
|
|
___/___/______ |
__ __ : __ __ |
am pm |
positive negative |
___/___/______ |
__ __ : __ __ |
am pm |
Species (check all that apply) Vivax Falciparum Malariae Ovale Not Determined Other species (specify) __________________ Parasitemia (%): _______________________ |
Public reporting burden of this collection of information is estimated to average 10 minutes per response. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Please send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Rd., NE (MS D-24); Atlanta, GA 30333; ATTN: PRA (0920-1026).
Was a travel history taken for this patient? Yes No Unknown |
|||||||
Is the patient a US resident? Yes No Unknown |
|||||||
Has the patient traveled or lived outside the U.S. since December 2013? Yes No If yes, specify: |
|||||||
Country: |
1. ________________ |
2. _________________ |
3. ________________ |
||||
Date ARRIVED IN the country (mm/dd/yyyy): Date DEPARTED the country (mm/dd/yyyy): |
____/ ____/ ______ ____/ ____/ ______ |
____/ ____/ ______ ____/ ____/ ______ |
____/ ____/ ______ ____/ ____/ ______ |
||||
|
|
|
|
||||
Clinical Cerebral malaria ARDS None Was illness fatal: Yes No Unknown Complications: Renal failure Severe anemia(Hb<7) Other : ____________ If yes, date of death : _____/____/_______
|
|||||||
|
|||||||
Therapy for this attack (check all that apply) |
Was this medication given? |
Date
and time medication given |
|||||
Artemether/lumefantrine (Coartem) |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
|||
Artesunate |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
|||
Atovaquone-Proguanil (Malarone) |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
|||
Chloroquine |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
|||
Clindamycin |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
|||
Doxycycline |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
|||
Mefloquine |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
|||
Quinidine |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
|||
Quinine |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
|||
Other (specify): _____________________ |
Yes Unknown No |
___/___/______ |
__ __ : __ __ |
am pm |
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | MALARIA CASE SURVEILLANCE REPORT |
Author | CGH DPDM |
File Modified | 0000-00-00 |
File Created | 2021-01-27 |